Skip to main content

Table 2 Medications with decreased consumption found in the number of people in the DG

From: Improvement in prescriptions while maintaining overall health outcomes: a prospective observational study conducted in Japanese facilities for older people

 

Number of people taking medications

Difference

Percentage

Generic name

A. 2019

B. 2020

C. A-B

C/A

Magnesium Oxide a

170

118

52

30.6%

Levamipide

38

6

32

84.2%

Amlodipine Besil

118

88

30

25.4%

Heparinoid

49

20

29

59.2%

Loxoprofen a

36

16

20

55.6%

Ketoprofen a

30

11

19

63.3%

Dimethylisopropyl azulene

29

11

18

62.1%

Sennoside

72

54

18

25.0%

White Vaseline

31

13

18

58.1%

Ambroxol

22

5

17

77.3%

Acetaminophen

41

26

15

36.6%

Donepezil

53

39

14

26.4%

Famotidine a

23

9

14

60.9%

Betamethasone butyrate propionate

18

4

14

77.8%

Mosapride

19

5

14

73.7%

  1. a Generic name listed in the “Guidelines for medical treatment and its safety in the older people 2015”
  2. DG (decrement group), the participants whose number of medications decreased during the study period (between March 2019 and March 2020)